EQH vs. RYAN, ERIE, BRP, BRO, WTW, WPC, CNA, UDR, BIP, and KIM
Should you be buying Equitable stock or one of its competitors? The main competitors of Equitable include Ryan Specialty (RYAN), Erie Indemnity (ERIE), BRP Group (BRP), Brown & Brown (BRO), Willis Towers Watson Public (WTW), W. P. Carey (WPC), CNA Financial (CNA), UDR (UDR), Brookfield Infrastructure Partners (BIP), and Kimco Realty (KIM). These companies are all part of the "finance" sector.
Equitable (NYSE:EQH) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, community ranking, risk and institutional ownership.
Equitable pays an annual dividend of $0.88 per share and has a dividend yield of 2.3%. Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.9%. Equitable pays out 26.0% of its earnings in the form of a dividend. Ryan Specialty pays out 86.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Equitable is clearly the better dividend stock, given its higher yield and lower payout ratio.
92.7% of Equitable shares are held by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are held by institutional investors. 1.0% of Equitable shares are held by company insiders. Comparatively, 11.1% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Equitable had 3 more articles in the media than Ryan Specialty. MarketBeat recorded 8 mentions for Equitable and 5 mentions for Ryan Specialty. Equitable's average media sentiment score of 0.60 beat Ryan Specialty's score of 0.28 indicating that Equitable is being referred to more favorably in the media.
Equitable currently has a consensus target price of $39.67, indicating a potential upside of 4.18%. Ryan Specialty has a consensus target price of $54.25, indicating a potential upside of 6.85%. Given Ryan Specialty's higher probable upside, analysts clearly believe Ryan Specialty is more favorable than Equitable.
Equitable has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500.
Ryan Specialty has a net margin of 9.36% compared to Equitable's net margin of 0.00%. Ryan Specialty's return on equity of 44.84% beat Equitable's return on equity.
Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Equitable received 232 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.43% of users gave Equitable an outperform vote while only 38.33% of users gave Ryan Specialty an outperform vote.
Summary
Equitable beats Ryan Specialty on 13 of the 20 factors compared between the two stocks.
Get Equitable News Delivered to You Automatically
Sign up to receive the latest news and ratings for EQH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Equitable Competitors List
Related Companies and Tools
